{"id":13586,"date":"2022-01-18T09:00:13","date_gmt":"2022-01-18T15:00:13","guid":{"rendered":"https:\/\/backup.primeaction.com\/sp\/?p=13586"},"modified":"2022-01-11T18:54:59","modified_gmt":"2022-01-12T00:54:59","slug":"alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu","status":"publish","type":"post","link":"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/","title":{"rendered":"Alemana Bayer impulsa investigaci\u00f3n en terapias gen\u00e9ticas en EEUU"},"content":{"rendered":"<p><img fetchpriority=\"high\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" data-src=\"https:\/\/udgtv.com\/wp-content\/uploads\/2022\/01\/Bayer-DPA2-1068x622.jpeg\" width=\"1068\" height=\"622\" class=\"aligncenter size-medium lazyload\" \/><noscript><img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/udgtv.com\/wp-content\/uploads\/2022\/01\/Bayer-DPA2-1068x622.jpeg\" width=\"1068\" height=\"622\" class=\"aligncenter size-medium\" \/><\/noscript><\/p>\n<p>El consorcio farmac\u00e9utico y agroqu\u00edmico alem\u00e1n Bayer quiere reforzar su todav\u00eda incipiente negocio de terapias gen\u00e9ticas y celulares mediante la cooperaci\u00f3n con Mammoth Biosciences, un especialista estadounidense en modificaci\u00f3n g\u00e9nica, seg\u00fan anunci\u00f3 hoy en Berl\u00edn la compa\u00f1\u00eda germana.<\/p>\n<p>La compa\u00f1\u00eda explic\u00f3 que espera desarrollar en un inicio tratamientos para enfermedades hep\u00e1ticas con la ayuda de la tecnolog\u00eda de las llamadas tijeras gen\u00e9ticas de la compa\u00f1\u00eda norteamericana. Bayer expres\u00f3 su deseo de poder crear terapias m\u00e1s r\u00e1pidamente con esta tecnolog\u00eda.<\/p>\n<p>Como parte de la cooperaci\u00f3n con Mammoth, Bayer aportar\u00e1 40 millones de d\u00f3lares (35,29 millones de euros) en una primera etapa, y en funci\u00f3n de los objetivos alcanzados, en el futuro podr\u00eda a\u00f1adir m\u00e1s de mil millones de d\u00f3lares.<\/p>\n<p>Adem\u00e1s, seg\u00fan detall\u00f3 la empresa germana, se contempla la posibilidad de realizar pagos en concepto de investigaci\u00f3n y una participaci\u00f3n en las ventas.<\/p>\n<p>Una de las cofundadoras de Mammoth es Jennifer Doudna, quien, junto con la francesa Emmanuelle Charpentier, recibi\u00f3 el Premio Nobel de Qu\u00edmica en 2020 por el desarrollo de unas tijeras gen\u00e9ticas para la modificaci\u00f3n dirigida de genes.<\/p>\n<p>La t\u00e9cnica, denominada CRISPR-Cas, puede utilizarse para la edici\u00f3n selectiva del genoma, es decir, la eliminaci\u00f3n, inserci\u00f3n y modificaci\u00f3n del ADN.<\/p>\n<p>A la vista de estas posibilidades, Bayer -al igual que otras compa\u00f1\u00edas farmac\u00e9uticas- lleva tiempo apostando por las terapias gen\u00e9ticas y celulares, que buscan contener enfermedades hasta ahora intratables.<\/p>\n<p>Entre las adquisiciones de Bayer en Estados Unidos, destacan la de las biotecnol\u00f3gicas estadounidenses Bluerock Therapeutics en 2019 y Asklepios BioPharmaceutical (AskBio) en 2020.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El consorcio farmac\u00e9utico y agroqu\u00edmico alem\u00e1n Bayer quiere reforzar su todav\u00eda incipiente negocio de terapias gen\u00e9ticas y celulares mediante la cooperaci\u00f3n con Mammoth Biosciences, un especialista estadounidense en modificaci\u00f3n g\u00e9nica, seg\u00fan anunci\u00f3 hoy en Berl\u00edn la compa\u00f1\u00eda germana.<\/p>\n","protected":false},"author":10,"featured_media":13588,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"single-post.php","format":"standard","meta":{"_eb_attr":"","site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_mbp_gutenberg_autopost":false,"fifu_image_url":"https:\/\/udgtv.com\/wp-content\/uploads\/2022\/01\/Bayer-DPA2-1068x622.jpeg","fifu_image_alt":"Alemana Bayer impulsa investigaci\u00f3n en terapias gen\u00e9ticas en EEUU","footnotes":""},"categories":[6],"tags":[],"class_list":["post-13586","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-post-agronegocios"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alemana Bayer impulsa investigaci\u00f3n en terapias gen\u00e9ticas en EEUU &#183; Prime Action Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alemana Bayer impulsa investigaci\u00f3n en terapias gen\u00e9ticas en EEUU &#183; Prime Action Consulting\" \/>\n<meta property=\"og:description\" content=\"El consorcio farmac\u00e9utico y agroqu\u00edmico alem\u00e1n Bayer quiere reforzar su todav\u00eda incipiente negocio de terapias gen\u00e9ticas y celulares mediante la cooperaci\u00f3n con Mammoth Biosciences, un especialista estadounidense en modificaci\u00f3n g\u00e9nica, seg\u00fan anunci\u00f3 hoy en Berl\u00edn la compa\u00f1\u00eda germana.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/\" \/>\n<meta property=\"og:site_name\" content=\"Prime Action Consulting\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-18T15:00:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/udgtv.com\/wp-content\/uploads\/2022\/01\/Bayer-DPA2-1068x622.jpeg\" \/>\n<meta name=\"author\" content=\"primeactionmx\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/udgtv.com\/wp-content\/uploads\/2022\/01\/Bayer-DPA2-1068x622.jpeg\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"primeactionmx\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alemana Bayer impulsa investigaci\u00f3n en terapias gen\u00e9ticas en EEUU &#183; Prime Action Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/","og_locale":"es_ES","og_type":"article","og_title":"Alemana Bayer impulsa investigaci\u00f3n en terapias gen\u00e9ticas en EEUU &#183; Prime Action Consulting","og_description":"El consorcio farmac\u00e9utico y agroqu\u00edmico alem\u00e1n Bayer quiere reforzar su todav\u00eda incipiente negocio de terapias gen\u00e9ticas y celulares mediante la cooperaci\u00f3n con Mammoth Biosciences, un especialista estadounidense en modificaci\u00f3n g\u00e9nica, seg\u00fan anunci\u00f3 hoy en Berl\u00edn la compa\u00f1\u00eda germana.","og_url":"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/","og_site_name":"Prime Action Consulting","article_published_time":"2022-01-18T15:00:13+00:00","og_image":[{"url":"https:\/\/udgtv.com\/wp-content\/uploads\/2022\/01\/Bayer-DPA2-1068x622.jpeg","type":"","width":"","height":""}],"author":"primeactionmx","twitter_card":"summary_large_image","twitter_image":"https:\/\/udgtv.com\/wp-content\/uploads\/2022\/01\/Bayer-DPA2-1068x622.jpeg","twitter_misc":{"Escrito por":"primeactionmx","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/#article","isPartOf":{"@id":"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/"},"author":{"name":"primeactionmx","@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/person\/12b4e201995201db2de1bc5b99533471"},"headline":"Alemana Bayer impulsa investigaci\u00f3n en terapias gen\u00e9ticas en EEUU","datePublished":"2022-01-18T15:00:13+00:00","mainEntityOfPage":{"@id":"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/"},"wordCount":300,"publisher":{"@id":"https:\/\/backup.primeaction.com\/sp\/#organization"},"image":{"@id":"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/#primaryimage"},"thumbnailUrl":"https:\/\/udgtv.com\/wp-content\/uploads\/2022\/01\/Bayer-DPA2-1068x622.jpeg","articleSection":["Post Agronegocios"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/","url":"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/","name":"Alemana Bayer impulsa investigaci\u00f3n en terapias gen\u00e9ticas en EEUU &#183; Prime Action Consulting","isPartOf":{"@id":"https:\/\/backup.primeaction.com\/sp\/#website"},"primaryImageOfPage":{"@id":"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/#primaryimage"},"image":{"@id":"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/#primaryimage"},"thumbnailUrl":"https:\/\/udgtv.com\/wp-content\/uploads\/2022\/01\/Bayer-DPA2-1068x622.jpeg","datePublished":"2022-01-18T15:00:13+00:00","breadcrumb":{"@id":"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/#primaryimage","url":"https:\/\/udgtv.com\/wp-content\/uploads\/2022\/01\/Bayer-DPA2-1068x622.jpeg","contentUrl":"https:\/\/udgtv.com\/wp-content\/uploads\/2022\/01\/Bayer-DPA2-1068x622.jpeg","caption":"Alemana Bayer impulsa investigaci\u00f3n en terapias gen\u00e9ticas en EEUU"},{"@type":"BreadcrumbList","@id":"https:\/\/backup.primeaction.com\/sp\/alemana-bayer-impulsa-investigacion-en-terapias-geneticas-en-eeuu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/backup.primeaction.com\/sp\/"},{"@type":"ListItem","position":2,"name":"Alemana Bayer impulsa investigaci\u00f3n en terapias gen\u00e9ticas en EEUU"}]},{"@type":"WebSite","@id":"https:\/\/backup.primeaction.com\/sp\/#website","url":"https:\/\/backup.primeaction.com\/sp\/","name":"Prime Action Consulting","description":"Consultoria Especializada em Canais","publisher":{"@id":"https:\/\/backup.primeaction.com\/sp\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/backup.primeaction.com\/sp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/backup.primeaction.com\/sp\/#organization","name":"Prime Action Consulting","url":"https:\/\/backup.primeaction.com\/sp\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/logo\/image\/","url":"https:\/\/backup.primeaction.com\/sp\/wp-content\/uploads\/sites\/8\/2019\/11\/logo-horiz-01-transp-2.png","contentUrl":"https:\/\/backup.primeaction.com\/sp\/wp-content\/uploads\/sites\/8\/2019\/11\/logo-horiz-01-transp-2.png","width":400,"height":185,"caption":"Prime Action Consulting"},"image":{"@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/person\/12b4e201995201db2de1bc5b99533471","name":"primeactionmx","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/19d334fbde47ddf970c0d3392d592bcaec217ee5e078358913a249e212d2899f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/19d334fbde47ddf970c0d3392d592bcaec217ee5e078358913a249e212d2899f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/19d334fbde47ddf970c0d3392d592bcaec217ee5e078358913a249e212d2899f?s=96&d=mm&r=g","caption":"primeactionmx"},"url":"https:\/\/backup.primeaction.com\/sp\/author\/primeactionmx\/"}]}},"_links":{"self":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts\/13586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/comments?post=13586"}],"version-history":[{"count":1,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts\/13586\/revisions"}],"predecessor-version":[{"id":13587,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts\/13586\/revisions\/13587"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/media\/13588"}],"wp:attachment":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/media?parent=13586"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/categories?post=13586"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/tags?post=13586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}